Contributors
xiii
P.A. Jose • Department of Medicine and Physiology, University of Maryland School of Medicine, Baltimore, MD, USA Henry L. Keen • Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA, USA B.A. Kemp • Division of Endocrinology and Metabolism, University of Virginia, Charlottesville, VA, USA Alison J. Kriegel • Department of Physiology, Medical College of Wisconsin, Milwaukee, WI, USA Ivana Y. Kuo • Department of Pharmacology, School of Medicine, Yale University, New Haven, CT, USA Terry Kurth • Department of Physiology, Medical College of Wisconsin, Milwaukee, WI, USA Francisco R.M. Laurindo • Vascular Biology Laboratory, Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil Roberto Q. Lautner • National Institute of Science and Technology in Nanobiopharmaceutics, Federal University of Minas, Gerais, Brazil Department of Physiology and Biophysics, Biological Science Institute, Federal University of Minas, Gerais, Brazil Eric Lazartigues • Department of Pharmacology and Experimental Therapeutics and Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, USA Mingyu Liang • Center of Systems Molecular Medicine, Department of Physiology, Medical College of Wisconsin, Milwaukee, WI, USA Yong Liu • Department of Physiology, Medical College of Wisconsin, Milwaukee, WI, USA Gervaise Loirand • INSERM, UMR_S1087-CNRS UMR_C6291, Nantes, France; CHU de Nantes, Nantes, France; CHU de Nantes, l’institut du thorax, Nantes, France Rheure A.M. Lopes • British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK Alicia N. Lyle • Division of Cardiology, Department of Medicine, Emory University, Atlanta, GA, USA Scott M. MacKenzie • BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK Koren K. Mann • Lady Davis Institute for Medical Research and Department of Oncology Jewish General Hospital, McGill University, Montreal, QC, Canada David L. Mattson • Center of Systems Molecular Medicine, Department of Physiology, Medical College of Wisconsin, Milwaukee, WI, USA Martin McBride • Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK H.E. McGrath • Department of Pathology, Univeristy of Virginia, Charlottesville, VA, USA Walmor C. De Mello • School of Medicine, Medical Sciences Campus UPR, San Juan, PR, USA Harald Mischak • School of Natural Sciences, University of Stirling, Stirling, UK; Mosaiques Diagnostics GmbH, Hannover, Germany; Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK
